Podcast
Ep. 03 — The Trial CFO
Trial economics and the new unit cost of evidence generation.
Listen to the episode
Audio / Video Embed Placeholder
Replace with the embed code for your podcast player (Spotify, Apple Podcasts, YouTube, or self-hosted audio/video).
About this episode
Trial economics and the new unit cost of evidence generation.
In this episode of The Maxis AI Podcast, our host sits down with an industry leader to unpack "Ep. 03 — The Trial CFO". The conversation moves from first principles to lived operational reality — what's actually changing in clinical R&D, why now, and what teams are doing about it.
Expect a candid discussion: where agentic AI is delivering measurable impact, where it isn't, and the governance models that make production deployments durable in GxP environments.
Key takeaways
- Why traditional clinical workflows are reaching a structural breaking point — and what's driving the shift now.
- How agentic AI is being applied in production today across study startup, data management, and biometrics.
- What governance, oversight, and reviewer-in-the-loop patterns actually work in regulated environments.
- Where leading sponsors and CROs are recovering the most cycle time and cost — with concrete benchmarks.
- What the next 12–24 months look like for AI adoption across clinical R&D, and how to prepare your team.
Host & Guest
Anika leads Maxis AI's clinical agent practice, working with sponsors and CROs on governed deployments across CDM, biometrics, and oversight.
Explore our AI Workforce Platform
See how AI agents are transforming study startup, data management, oversight, and regulatory submissions.